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Abstract
Background: Genomic comparison of Mycoplasma synoviae vaccine strain MS-H and the MS-H parental strain 86,
079/7NS established a preliminary profile of genes related to attenuation of MS-H. In this study we aimed to
identify the stability of mutations found in MS-H after passage in experimental or field chickens, and to evaluate if
any reverse mutation may be associated with changes in characteristics of MS-H in vitro or in vivo.
Results: Whole genome sequence analysis of 5 selected MS-H field reisolates revealed that out of 32 mutations
reported previously in MS-H, 28 remained stable, while four found to be reversible to the wild-type. Each isolate
possessed mutations in one to three of the genes obg, oppF1 and gap and/or a non-coding region. Examination of
the 4 reversible mutations by protein modeling predicted that only two of them (in obg and oppF1 genes) could
potentially restore the function of the respective protein to that of the wild-type.
Conclusions: These results suggest that the majority of the MS-H mutations are stable after passage in vaccinated
chickens. Characterisation of stable mutations found in MS-H could be utilised to develop rapid diagnostic
techniques for differentiation of vaccine from field strains or ts- MS-H reisolates.
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Background
Mycoplasma synoviae (MS) is a major poultry pathogen,
and due to its high economic impact on sectors of the
chicken and turkey industries [1] has been listed as a ser-
ious disease of poultry by the World Organization for Ani-
mal Health (OIE, http://www.oie.int/animal-health-in-the-
world/oie-listed-diseases-2019/). Control of the disease
caused by MS through biosecurity and serological moni-
toring is often insufficient [2]. Therefore, live attenuated
vaccines are used when the prevention of exposure is im-
practical. The most commonly used commercial MS vac-
cine in Australia (Vaxsafe MS®; Bioproperties Ltd.,
Ringwood, Victoria, Australia) is a temperature sensitive
(ts+) strain (MS-H) which was developed by chemical mu-
tagenesis of an Australian field isolate 86,079/7NS [3].
A wide range of ts + viruses and bacteria have been
used as vaccine candidates, but in many cases it is not
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exactly known whether temperature sensitivity is the
cause of attenuation or just a coincidental phenotype in
these organisms [4, 5].
The majority of MS clones recovered from vaccinated
flocks display their ts + phenotype, but it has been sug-
gested that MS-H proliferation in vaccinated birds gen-
erates a mixture of ts + and ts- clones in the farm [6, 7].
Unlike the non-virulent MSH strain, ts- field reisolates
cause only minor lesions in the tracheal mucosa of the
experimentally infected birds, significantly lower than
the vaccine parent strain [7]. These results suggest that
factors other than ts + phenotype are involved in the at-
tenuation of the MS-H vaccine.
While the genetic basis of the MS-H temperature sen-
sitivity and attenuation is not fully known yet, a muta-
tion detected in obg gene was proposed as a likely
explanation for the MS-H ts + phenotype [8]. Also, fur-
ther comparison of the MS-H genome with that of its
wild-type parent strain 86,079/7NS has revealed a frame-
shift mutation in an oligopeptide permease transporter
(opp) gene, oppF1 [9]. OppF is essential in establishment
of systemic infection by M. bovis and its persistence in
lower respiratory tract of calves [10]. Also, oppD was
found to be required for full expression of virulence of
M. gallisepticum in chickens [11].
Partial sequence analysis of obg and oppF genes [8,
12] in five MS-H isolates have found different combi-
nations of obg and oppF genotypes. Of the five iso-
lates, MS-H3, 101,564 and 101,731 had obgw (w =
wild-type) and oppFv (v = vaccine-type), MS-H4 had
obgw and oppFw, and MS-H5 had obgv and oppFw. In
this study the MS-H reisolates MS-H3, 101,564, 101,
731 MS-H4, and MS-H5 were subjected to a
comparative genome analysis to establish if any other
mutations previously reported for the MS-H [12] may
be reversible to the wild-type and evaluate if they
could potentially influence MS-H attenuation.
Results
Phylogenetically, all selected reisolates from vaccinated
flocks were closely related to MS-H
Illumina paired reads from MS-H field isolates (Gen-
Bank accession number PRJNA649354) were De
novo assembled successfully using SPAdes with an
average 162 of contigs generated for each ranging
from 125 to 131,331 bp per isolate. The vlhA
pseudogene region, a ~ 50 kb locus covering large
number of highly repetitive sequences, as well as the
repetitive and the highly similar IS failed to assem-
ble. Otherwise, the SPAdes generated an average
790,468 bp, representing a complete genome with
high identity (93%) to other MS sequences available
in the Gene Bank [12–16]. Alignment of the draft
genomes of MS-H field isolates with that of MS-H
exhibited an overall high degree of sequence similar-
ity (99.99%) with no large-scale chromosomal inser-
tions, deletions, duplications or rearrangements
except for vlhA locus.
The maximum likelihood and NJ analysis performed
using platforms REALPHY and MEGA, respectively, on
whole genome sequences of 7 MS strains/isolates gener-
ated highly comparable results, reflecting a close rela-
tionship between MS-H and its field isolates. Notably,
MS-H3 and MS-H4 were respectively the most closely
and distantly related to MS-H (Fig. 1).
Fig. 1 Phylogenetic tree from seven MS strains/isolates. The phylogenetic tree was inferred from whole genome comparison of seven MS strains/
isolates using Neighbor Joining (NJ) and Maximum likelihood methods. The scale bar shows the distance
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Of the 32 mutations previously found between 86,079/
7NS and MS-H, only four were observed to have reversed
Comparative genomic analysis found a total of 25 SNP
and indel variants between MS-H and its field isolates
(Table 1). MS-H4 and MS-H3 had the highest (12) and
the lowest (1) number of genomic differences with MS-
H, respectively, while MS-H5, 101,546 and 101,731 had
4, 7 and 7 differences, respectively. Four out of these 25
SNPs had been detected in a previous study that com-
pared the genomes of MS-H and its parent strain 86,
079/7NS [12], however the other 21 were found only in
the 5 reisolates.
The MS-H3 had an identical sequence to MS-H ex-
cept for the coding DNA sequence (CDS) of oppF in
which insertion of ‘T’ at position 468 resulted in the
restoration of the full-length oppF sequence identical
to that of 86,079/7NS.
Three non-synonymous differences were found be-
tween genomes of MS-H and MS-H5. These included
deletion of two nucleotides ‘AT’ in a tandem repeat in a
non-coding region (positions 502,825) upstream of the
cytosine-5-methyltransferase CDS, insertion of nucleo-
tide ‘A’ (causing frame-shift mutation) in a gene (CDS
164) encoding a protein of unknown function, and nu-
cleotide substitution ‘A’ to ‘G’ in obg gene resulting in
restoration of the wild-type Obg (Arg123Gly). Also, a
synonymous substitution (‘C’ to ‘T’) in Glu322 was
found in the CDS 966 which codes for Desert Hedgehog
Signalling Molecule.
Twelve genomic differences were found between MS-H4
and MS-H, three of which had been described to exist be-
tween MS-H and 86,079/7NS and were reverted to wild-
type sequence. These comprised of insertion of ‘AT’ at
position 502,827 in a tandem repeat within a non-coding
region, a SNP in obg gene (similar to that found in MS-
H5) and a frameshift mutation in the oppF gene (identical
to that found in MS-H3). The other 9 mutations com-
prised of 6 in genes coding for Cardiolipin, two
hypothetical protein, TatD deoxyribonuclease, S1 RNA-
binding domain, and Thymidine phosphorylase, 1 in a
gene with unknown function, 2 in non-coding regions.
In the isolate 101,546, two genomic differences were
found to cause reversion to wild-type sequence. These
included ‘A’ to ‘G’ in gap gene (at CDS 554) which re-
sulted in a conservative change (Ala185Val), and a
frameshift mutation in oppF identical to that from MS-
H3 and MS-H4. Moreover, four non-synonymous substi-
tutions were found in CDSs corresponding to Obg,
YbhB/YbcL Raf kinase inhibitor, and two hypothetical
proteins. These substitutions were due to ‘C’ to ‘T’ at
CDS 629 in obg gene resulting in a conservative change
(Ala210Val); ‘C’ to ‘A’ at CDS 909 causing a conservative
change (Asp303Glu) in a gene encoding a hypothetical
protein; ‘G’ to ‘A’ at CDS 220 resulting a conservative
change (Val74Ile) in gene encoding YbhB/YbcL Raf kin-
ase inhibitor, and ‘C’ to ‘T’ at CDS 3979 resulting in a
non-conservative substitution (Ala1327Thr). Moreover,
a synonymous substitution in Thr197 was found in CDS
corresponding to LemA (‘C’ to ‘T’ at CDS 591).
Comparison of MS-H and 101,731 were found changes
in obg and oppF genes consistent with those of 1,015,
465. Moreover, similar to MS-H4, ‘AT’ insertions at po-
sitions 502,827 was found resulting in reversion to wild-
type sequence. In addition, a ‘T’ deletion at CDS 387 in
a gene encoding a hypothetical protein, substituted
Tryr135 to a premature stop-codon. Moreover, genes
encode Cls and DNA-directed RNA polymerase subunit
beta were found to have a ‘G’ to ‘A’ substitution which
resulted in a conservative amino acid change (Ser263-
Asn), and a ‘T’ to ‘C’ substitution which resulted in a
non-conservative substitution (Glu1037Gly), respect-
ively. Additionally, a synonymous substitution in Asx362
was found in CDS corresponding to a hypothetical pro-
tein (‘G’ to ‘A’ at CDS 1086).
Table 1 Nucleotide and coding differences identified among the genomes of 86,079/7NS, MS-H and 5 MS-H field isolates
Kordafshari et al. BMC Genomics          (2020) 21:598 Page 3 of 10
Mutations found in genes coding for Obg, OppF,
Cardiolipin, and YbhB/YbcL Raf kinase-inhibitor were
computationally predicted to affect the proteins structure
The final alignment between targeted proteins and tem-
plates using Phyre2 for eight proteins (OppF, Obg, Cls,
TatD, S1 RNA-binding, NAD-dependent glyceraldehyde-
3-phosphate dehydrogenase, YbhB/YbcL Raf kinase in-
hibitor and DNA-directed RNA polymerase subunit beta)
exhibited an average 76% of residues modelled at 100%
confidence. For the other five proteins (hypothetical pro-
teins) only an average 40% of residues modelled at > 50%
confidence and none of residues modelled at > 90% confi-
dence (Table 2). The model template IDs, protein lengths,
predicted secondary structures, and the degree (%) of mu-
tation sensitivity at a given position in the respective pro-
teins are detailed in Table 2.
Consistent with findings from a previous study [8],
homology modelling of Obg in MS-H showed that
Arg123 is located in large pocket region, which are fre-
quently the active sites [17], however the probability that
a missense mutation at this position effecting function
of the corresponding protein was predicted low. The
percentages of predicted alpha helices in the Obg pro-
tein sequences of MS-H4 or MS-H5 (29%), was different
from that of MS-H (26%), due to the Arg123Gly differ-
ence between these strains. By contrast, the Ala210Val
difference in the Obg protein sequence of strains 101,
546 and 101,731 did not change the secondary structure
of Obg compared to that of MS-H.
The frameshift mutation corresponding to oppF gene
in MS-H3, MS-H4, 101,546 and 101,731 restored the
full-length OppF (reversion to wild-type). Based on the
protein homology analysis conducted as part of this
study, the functional domain of OppF is identified at the
C terminus. As a result, the secondary structure of OppF
in above-mentioned isolates (which possessed 68% alpha
helices and 7% beta strands) was significantly different to
that of MS-H (31% alpha helices and 24% beta strands).
Residue 166 in Cls of MS-H is in a highly sensitive muta-
tion region and therefore Ala166Thr in MS-H4 was pre-
dicted to affect its function. Also, due to this amino acid
change, the secondary structure of Cls in MS-H4 (contain-
ing 51% alpha helices) was different to that of MS-H (con-
taining 50% alpha helices). By contrast, amino acid at
position 263 was in a low mutation sensitive region. There-
fore, Ser263Asn was unlikely to affect the protein Cls func-
tion in isolate 101,731. Also, the secondary structure of Cls
in 101,731 was modelled identical to that from MS-H.
The TatD deoxyribonuclease and S1 RNA-binding
proteins were also modelled and compared between MS-
H and MS-H4 for their mutations at positions 143 and
57, respectively. In MS-H both these mutations were in
low sensitive mutation regions and therefore were un-
likely to affect the function of the respective proteins in
Table 2 Homology modelling results of proteins vary between
MS-H and its field isolates
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MS-H4. However, the latter substitution resulted in a
slight change in the percentage of alpha helices from
55% in MS-H to 56% in MS-H4, and this could poten-
tially alter the secondary structure of the protein.
The Arg185 in NAD-dependent glyceraldehyde-3-
phosphate dehydrogenase in MS-H was in a low muta-
tion sensitive region. The Arg185lys could potentially
change the secondary structure of the protein in 101,546
compared to that of MS-H as the percentage of beta
strands changed from 31% in MSH to 32% in 101,546.
The protein YbhB/YbcL Raf kinase inhibitor was also
modelled in MS-H and 101,546. Residue Val74 was
found in a highly sensitive mutation region and therefore
Val74Ile could potentially affect the function of the re-
spective protein in 101,546. The secondary structure of
this protein was identical in MS-H and 101,546.
The effect of Glu1037Gly in DNA-directed RNA poly-
merase subunit beta in 101,731 was found neutral as
Glu1037 was located in a low sensitive mutation site and
the secondary structure of respective protein was identi-
cal in MS-H and 101,731.
Full-length OppF was detected in all MS-H reisolates
Amongst all mutations detected in MS-H reisolates, the
frameshift mutation in the oppF gene appeared to have
the most significant impact on the structure of its
encoded protein and therefore was further investigated.
The wild-type oppF was predicted to encode a
polypeptide of 797 amino acids (approximately 94 kDa).
Immunoblotting experiments with rabbit-anti-OppF-N
antibodies detected the OppF protein of expected size
(~ 94 kDa) in 86,079/7NS, MS-H3, MS-H4, 101,546 and
10,173,118, while did not detect any protein of similar
size in MS-H and MS-H5 cells (Fig. 2). The rabbit-anti-
OppF-N antibodies also detected several presumably
nonspecific bands of similar sizes in all MS strains/iso-
lates lysates tested.
Discussion
This is the first study that investigates the stability of all
mutations in a live attenuated mycoplasma vaccine after
in vivo passage under field conditions. The initial swab
cultures collected from MS-H vaccinated birds were pas-
saged three times in vitro by selection of an individual
colony from each step. It may be possible that in vitro
passage of the clones may have incorporated selection
pressure and bias into the expansion of a clonal popula-
tion, however it is notable that the clones were com-
pared against an in vitro propagated MS-H vaccine
strain. Whole genome sequencing directly from clinical
materials collected from vaccinated birds would be ideal
to circumvent the potential of in vitro selection pressure,
but currently available does not allow compilation of
complete genome sequence reliable at a base pair level.
Also, current techniques may run the risk of generating
Fig. 2 Analysis of OppF expression in MS strains/isolates. Western Immunoblots of recombinant purified OppF and whole-cell lysate from MS
strains/isolates probed with rabbit-anti-OppF-N. The arrow heads show the location of full-length OppF. M is Precision Plus protein TM, Dual Color
marker (Bio-Rad)
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a chimeric genome generated from multiple clonal pop-
ulations that may cohabit the bird’s respiratory system.
A recent study [12] described 32 mutations within the
MS-H genome as compared to its parent strain 86,079/
7NS. However, the stability of these mutations after pas-
sage in vivo had only been tested for those found in obg
[8] and oppF [9].
Protein homology modelling found that four sequence
variations between MS-H and reisolates from vaccinated
flocks, located in genes coding for Obg, OppF, Cardioli-
pin, and YbhB/YbcL Raf kinase-inhibitor, were likely to
affect the in vitro and/or in vivo characteristics of MS.
Given that oppF is involved in pathogenesis of M.
bovis [10], and the wild-type OppF from MS shares 43%
amino acid similarity with that of M. bovis, the genomes
of five MS-H field isolates differing in the oppF gene
with that from MS-H and 86,079/7NS was analysed in
this study to reflect the possible role of oppF in
temperature sensitivity/attenuation phenotype of MS-H.
Mycoplasmas can survive in vivo due to complex inter-
action between the microorganism and the host environ-
ment [18]. A continuous source of a nutrient used by a
gene that is essential for in vivo survival may be a vital
factor in the capability of a pathogen to cause disease
[10]. Several nutrients are gained from exogenous
sources by mycoplasmas as a result of their limited syn-
thesis pathways. Hence, the ability to integrate molecules
over membrane-associated transport systems appears to
be a substantial factor for in vivo survival of mycoplas-
mas. In M. bovis, two transporters (oligopeptide trans-
porter oppABCDF and an uncharacterized transporter)
were essential for colonization on the tracheal mucosa
[10]. In M. mycoides subsp. mycoides, a glycerol trans-
porter (gtsABC) has been specified as a virulence factor
related with hydrogen peroxide production and induc-
tion of cytotoxicity [19–21]. The level of mRNA expres-
sion of oppD of M. hyopneumoniae was moderately up-
regulated throughout in vivo infection [22] and under
iron-depletion conditions [23]. Therefore, all available
studies on the role of OppF in several Mycoplasma spe-
cies are highly suggestive that OppF has a major contri-
bution to the attenuation of MS-H. It is notable that in
Western Immunoblot analysis conducted as part of this
study, the truncated OppF was not delectable in MS-H
and MS-H5 (Fig. 2). It is speculated that the truncated
version of OppF does not react well with polyclonal anti-
body against N terminus of OppF. The repeat of this
Western Immunoblot in this and our previous publica-
tion [24] has shown that truncated version of OppF has
only minimal reaction against anti-OppF-N polyclonal
antibody. It is postulated that most of epitopes of this
antibody are probably conformational (as opposed to lin-
ear) and may require of the remaining OppF protein to
fully react and provide a readily detectable band on
Western Immunoblot.
In bacteria, the Cardiolipin levels have been found to
elevate in the stationary growth phase due to up-
regulation of Cls activity in response to osmotic stress
[25]. The importance of anionic phospholipids cl in the
osmotic adaptation and in the membrane structure of
Bacillus subtilis cultures was demonstrated by impair-
ment of osmotolerance in a Cls mutant (clsA) of this or-
ganism. As well as the lack in cl synthesis, this mutant
indicated other deficiencies in lipid and fatty acid con-
tent compared to the wild-type, signifying a cross-
regulation in membrane lipid pathways, critical for the
conservation of membrane functionality and integrity
[25]. Therefore, it appears that elucidation of the role of
Cardiolipin in attenuation of MS-H needs further
investigation.
Given that the amino acid substitution in Cls of MS-
H4 was predicted to change secondary structure of the
respective protein compared to that of MS-H and muta-
tion resides in a highly sensitive mutation region, it is
likely that this mutation affects the function of the re-
spective protein in MS-H4.
The two proteins YbhB and YbcL belong to Raf kinase
family and play role in the regulation of protein phos-
phorylation by kinases in E. coli [26]. Phosphorylation
and dephosphorylation of proteins play a fundamnetal
role in signalling in bacteria [27, 28]. Previous studies
have confirmed the significance of the phosphorylation
of threonine and histidine residues and serine/threonine
kinases which were involved in pathogenicity and stress
responses in several prokaryotes [29]. Although the
Val74Ile substituion in YbhB/YbcL of isolate 101,546
was unlikey to influence the secondary structure of the
respective protein, it was found in a highly sensitive mu-
tation region and therefore could affect the function of
this protein.
Earlier studies in our laboratory have revealed that
GapA+ M. gallisepticum (MG) ts-11 vaccine was more
immunogenic and induced higher antibody response
than the GapA− ts-11 population [30]. In MG, the GapA
is determined as the primary cytadhesin molecule and is
known to play role in prolonged colonization and sur-
vival of MG [31, 32]. Interestingly, isolate 101,546 was
recovered from a MS-H vaccinated flock with unusually
high systemic antibody response to MS. This isolate had
a mutation in NAD-dependent glyceraldehyde-3-
phosphate dehydrogenase, located in large pocket re-
gions and found likely to change the secondary structure
of the respective protein compared to that of MS-H.
Comparative analysis of the genomes of selected MS
isolates from MS-H vaccinated flocks revealed that they
were true reisolates of the MS-H vaccine as they had
highly similar genome to that of MS-H as opposed to
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86,079/7NS. Results of this study also demonstrated that
out of 32 mutations found in MS-H genome [12], only
four to be reversible (Table 1) after passage in field birds.
Thus, the 28 other mutations appear to be stable in MS-
H. Of the four unstable mutations, twos (found in the
Obg and OppF), were predicted to have some effects on
MS virulence.
The mutations which are prone to revert are those
that provide advantages to the organism to grow faster
or grow in different parts of the respiratory system. For
example, reversion mutations in obg provide organism
higher capacity to live in lower respiratory system or
mutation in oppF provides organism utilising amino
acids more efficiently. These are important to drive re-
version to wild-type organism. The mutations that were
not found to revert organism to wild-type state probably
do not provide the vaccine a significant advantage
in vivo.
Given that obtaining pure cultures of the MS-H reiso-
lates characterised here had to undergo multiple steps of
growing in liquid and solid media, it may be possible
that some of the mutations detected were as a result of
in vitro passage. Future studies should therefore target
these mutations directly in clinical specimens collected
from vaccination chickens.
The data generated in this study also set the founda-
tion for future research aiming to develop strain identifi-
cation tests that reliably distinguish MS-H from other
MS strains that possess identical vlhA gene sequence.
Furthermore, using a set of mutations found here, it may
be possible to correlate results emerging from genotyp-
ing techniques to variations in characteristics of MS
isolates.
Conclusion
Results of this study reveal that most of the MS-H muta-
tions are stable after passage in vaccinated chickens.
Characterisation of stable mutations observed in MS-H
could be applied to develop rapid diagnostic techniques
for differentiation of vaccine from field strains or ts-
MS-H reisolates.
Methods
MS strains, growth conditions, and DNA extraction
All MS-H isolates used in this study (Table 3) were
made from flocks vaccinated with MS-H at various times
after vaccination. All initial swab cultures were cloned
by selection of individual colonies three times. The MS-
H isolates were grown in mycoplasma broth supple-
mented with 10% swine serum (Sigma-Australia) and
0.01% (w/v) of nicotinamide adenine dinucleotide
(NAD) (Sigma-Australia) [33] at 37 °C in a 50 mL final
volume until late logarithmic phase (approximately pH
6.8). Cells were collected followed by extraction of
genomic DNA as described previously [12]. The DNA
concentration was measured using the optical density at
260 nm (OD260) using a NanoDrop™ 2000c spectropho-
tometer (Thermo Fisher Scientific, Waltham, MA, USA)
and purity was evaluated by calculating the OD260/280
ratio. The integrity of DNA was assessed using chroma-
tography through 0.8% agarose gel and DNA products
were stored at − 80 °C until use.
Next-generation sequencing (NGS)
NGS of all MS-H field isolates was performed using
Paired-end 125-bp reads by the Illumina MiSeq platform
at the Australian Genome Research Facility Ltd. (AGRF,
Melbourne, VIC, Australia).
De novo assembly and sequence analysis
SPAdes assembler version 3.10.0 (Geneious® version
11.1.3) was used to perform De Novo assembly of con-
tiguous sequences. To visualize overall sequence similar-
ity and identify genomic organisation between the MS-H
and its field isolates, the contigs were aligned to MS-H
genome (GenBank accession number CP021129) as ref-
erence using Mauve (Mauve Contig Mover (MCM)),
Geneious®. The MCM aligns a draft genome to a refer-
ence sequence and orders the contigs in the draft gen-
ome according to their position along the reference
genome [34, 35].
The resulting contigs and Illumina short reads were
mapped to the MS-H genome using Geneious as mapper
in Geneious®. Subsequently the alignments were sub-
jected to single nucleotide polymorphism (SNP) and in-
sertion/deletion (indel) analysis. To detect SNPs and
indels, ‘Find Variations/SNPs’ in Geneious® was used.
The genome sequence of strain 86,079/7NS (GenBank
accession numbers NZ_CP012624) was also included as
reference for analysis of SNPs.
Phylogenetic analysis
To establish the relationship of MS-H isolates (GenBank
accession number PRJNA649354), MS-H (GenBank ac-
cession number CP021129.1) and 86,079/7NS (GenBank
accession number CP012624.1), their whole genome se-
quence were analysed using maximum likelihood and
Neighbor Joining (NJ) methods and the DNA evolution-
ary models including GTR+ G+ I (GTR: General Time
Reversible; G: Gamma distribution; I: evolutionary in-
variable) and HKY85 (Hasegawa-Kishino-Yano) employ-
ing two programs REALPHY (version 1.12) [36] and
MEGA (version 10) [37].
Homology modelling of proteins vary between isolates
The Phyre2 (protein homology/analogy recognition en-
gine V 2.0) web portal for protein modelling, prediction
and analysis (http://www.sbg.bio.ic.ac.uk/~phyre2/html/
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page.cgi?id=index) [38] was used for homology modelling
of proteins deduced from genes harboured SNP and indel
variants in MS-H field isolates. Intensive mode of model-
ling was selected which performs complete modelling of
the entire protein using multiple templates and ab initio
techniques. Furthermore, the resultant modelled protein
was subjected to Phyre investigator for more in-depth
analysis [39].
The crystal structure of the GTP-binding protein Obg
from Thermus thermophilus (protein data bank (PDB)
ID: c1udxA), ATP-binding/permease from Acinetobacter
baumannii (PDB ID: c5ws4A), Cardiolipin synthetase
Table 3 Summary of the isolates examined in this study
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(Cls) from (PDB ID: c3hsiC), hydrolase TatD family pro-
tein from Entamoeba histolytica (PDB ID: c3ipwA), Tex
family protein pa5201 from Pseudomonas aeruginosa
(PDB ID: c2oceA), Glyceraldehyde-3-phosphate2 de-
hydrogenase from Staphylococcus aureus (PDB ID:
c3hq4R), Pebp-like protein hp02182 from Helicobacter
pylori (PDB ID: c2evvD), and DNA-directed RNA poly-
merase subunit beta from Escherichia coli (PDB ID:
c3lu0C) were determined and used as homology models
for Obg, OppF, Cls, TatD deoxyribonuclease, S1 RNA-
binding domain, NAD-dependent glyceraldehyde-3-
phosphate dehydrogenase, YbhB/YbcL Raf kinase inhibi-
tor and DNA-directed RNA polymerase subunit beta,
respectively.
Detection of OppF expression in MS strains/isolates
One ml volumes of mycoplasma broth were inoculated
with 1/10 dilution of MS strains/isolates (Table 3) and
grown to late exponential phase (~ pH 6.8). The cells
were treated as described previously [24] and subjected
to sodium dodecyl sulfate–polyacrylamide gel electro-
phoresis (SDS-PAGE) followed by Immunoblotting with
mono-specific rabbit sera raised against N terminus of
OppF [24].
The MS 94011/V-18d and 86,079/7NS possessing full-
length oppF, MS-H possessing truncated oppF, and re-
combinant purified OppF [24] were used as controls.
Abbreviations
MS: Mycoplasma synoviae; ts +: Temperature sensitive; ts-: Non- temperature
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